Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.65
Bid: 3.50
Ask: 3.80
Change: 0.25 (7.35%)
Spread: 0.30 (8.571%)
Open: 3.40
High: 3.65
Low: 3.40
Prev. Close: 3.40
TAVI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of GM

20 Nov 2020 07:00

RNS Number : 8687F
Tavistock Investments PLC
20 November 2020
 

Tavistock Investments Plc

("Tavistock" or the "Company")

 

Notice of General Meeting

 

20 November 2020

 

Tavistock Investments Plc (AIM:TAVI) announces that it is convening a general meeting of the Company's shareholders (the "GM") at 11.30 am on Wednesday, 16 December 2020 at the Company's offices at 1 Bracknell Beeches, Old Bracknell Lane, Bracknell RG 12 7BW.

 

The purpose of the GM is to seek Shareholders' approval for the creation of a new class of growth shares and to make other minor amendments to the Company's Articles of Association to update them generally.

 

The Directors are looking to develop Tavistock into a significantly larger business and as a part of a wider focus on improving shareholder value, are now seeking to replace the use of share options as a means of incentivising the leadership team, including the Company's Executive Directors (being Oliver Cooke and Brian Raven) with an alternative incentive proposal that maintains the advantage of shareholders receiving the benefit of the Company's improving performance before any reward is achieved by the leadership team.

 

The accounting treatment of share options results in the Company incurring substantial share-based payment charges in its profit and loss account which adversely impact the level of its pre-tax profit. This potentially restricts the Board's ability to recommend dividend payments in the future.

 

The new proposal offers the Executive Directors and other members of the leadership team the potential of reward should they achieve more demanding performance hurdles than those attached to their current share options but also introduces peril (the risk of loss) for non-performance.

 

If the proposed arrangements are approved by shareholders and are implemented by the Board, the Executive Directors would intend to:

 

a) surrender, for nil consideration, all of the 58,200,000 share options that have been granted to them in the past; and

b) subscribe for a new class of growth shares, to be called "A Ordinary Shares", at £1 per A Ordinary Share - a price that is more than fifty times higher than the current market price of the Company's Ordinary Shares.

 

A surrender by the Executive Directors of all of their share options would trigger a reversal of the historic share-based payment charges and would result in the Company's profit before tax being enhanced by approximately £400,000 in the current financial year.

 

The Directors believe that the benefits offered to shareholders by the proposed arrangements include the following:

 

- an immediate enhancement of approximately £400,000 to the Company's pre-tax profit;

- potential further pre-tax profit enhancement as other members of the leadership team participate in the scheme; and

- a subscription of £100,000 into the Company by the Executive Directors at £1.00 per A ordinary Share.

 

For the leadership team to benefit from the proposed new arrangements they must first:

- waive the potential value of their existing share options for nil consideration;

- subscribe for A Ordinary Shares at a price that is more than fifty times higher than the current market price of the Company's Ordinary Shares; and

- achieve significantly more demanding performance targets.

 

A circular, containing details of the new incentive proposal and a formal notice convening the GM, is being sent to shareholders. A copy of the circular, together with a copy of the form of proxy, can be found on the Company's website at: https://tavistockinvestments.com/announcements.

 

Due to the current COVID-19 measures implemented by the Government in the United Kingdom SHAREHOLDERS WILL NOT BE PERMITTED TO ATTEND THE GM. The Company will ensure that the meeting is quorate and that the legal requirements are met.

 

SHAREHOLDERS WISHING TO VOTE ON THE RESOLUTION ARE STRONGLY URGED TO DO SO THROUGH COMPLETION OF THE FORM OF PROXY THAT IS BEING SENT TO THEM.

 

If shareholders have any questions or comments relating to the business of the meeting that they would like to put to the Board then they are requested to submit those questions in writing via email to GM161220@tavistockinvestmentsplc.com no later than 11.30 on 14 December 2020. The Board will publish a summary of any questions received which are of common interest, together with a written response on the Company's website as soon as practicable after the conclusion of the meeting.

 

The Board consider that the proposed incentive arrangements will be beneficial for the Company and its shareholders as a whole, and unanimously recommend that shareholders vote in favour of the resolution to be proposed at the GM, as they intend to do in respect of their aggregate shareholdings of 94,736,629 ordinary shares representing approximately 15.59% of the ordinary shares currently in issue.

 

 

Ends

 

Enquiries

Tavistock Investments Plc

Oliver Cooke

Brian Raven

Tel: 01753 867000

 

 

 

Allenby Capital Limited

Nick Naylor, Nick Athanas, Liz Kirchner (Corporate Finance)

 

Tony Quirke (Sales)

 

Tel: 020 3328 5656

 

 

Vested

Sophie Paterson

Tel: 07540 496 159

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGKKCBDKBDDPDD
Date   Source Headline
24th Mar 20217:00 amRNSStatement re Proposal from TEAM Plc
23rd Mar 202112:46 pmRNSRule 2.9 Announcement
23rd Mar 20217:05 amRNSPotential Offer for Tavistock Investments plc
12th Mar 20217:00 amRNSNotice of GM
11th Mar 20217:00 amRNSRescheduling of General Meeting
1st Mar 20217:00 amRNSNotice of GM
10th Feb 202112:01 pmRNSLetter to shareholders
9th Feb 20212:06 pmRNSSecond Price Monitoring Extn
9th Feb 20212:00 pmRNSPrice Monitoring Extension
9th Feb 20219:05 amRNSSecond Price Monitoring Extn
9th Feb 20219:00 amRNSPrice Monitoring Extension
9th Feb 20217:00 amRNSTrading Update
29th Jan 20217:00 amRNSDirector/PDMR Shareholding
28th Jan 20217:00 amRNSDirector/PDMR Shareholding
4th Dec 20207:00 amRNSPostponement of general meeting
20th Nov 20207:00 amRNSNotice of GM
10th Nov 20207:00 amRNSInterim Results
23rd Sep 202012:15 pmRNSResult of AGM & GM
14th Sep 20207:00 amRNSCorrection to no. of shares admitted to trading
9th Sep 20207:00 amRNSAppointment of Nominated Adviser & Rule 17 update
28th Aug 20207:00 amRNSNotice of AGM
23rd Jul 20209:07 amRNSFinal Results For Year Ended 31 March 2020
23rd Jul 20207:00 amRNSFinal Results For Year Ended 31 March 2020
24th Jun 20207:00 amRNSTrading Update
8th Apr 20207:00 amRNSTrading Update
19th Mar 202010:52 amRNSDirector/PDMR Shareholding
19th Mar 202010:01 amRNSDirector/PDMR Shareholding
19th Mar 20207:00 amRNSIssue of Shares to Strategic Investor
21st Nov 20197:00 amRNSInterim Results
1st Oct 20194:35 pmRNSDirector/PDMR Shareholding
30th Sep 201911:44 amRNSDirector/PDMR Shareholding
27th Sep 20196:09 pmRNSDirector/PDMR Shareholding
27th Sep 20197:00 amRNSTrading Update And Entry Into Loan Facility
25th Sep 20193:44 pmRNSResult of AGM
4th Sep 201912:11 pmRNSNotice of AGM
3rd Sep 20197:00 amRNSChange of Auditor
30th May 201911:49 amRNSTermination of Strategic Alliance with Lighthouse
15th May 20191:17 pmRNSPayment of Maiden Interim Dividend
15th May 20197:00 amRNSFinal Results
13th May 20197:00 amRNSNotice of results
9th May 20198:56 amRNSDirector/PDMR Shareholding
14th Feb 20197:00 amRNSPre-Close Trading Update
23rd Nov 20187:00 amRNSHolding(s) in Company
23rd Nov 20187:00 amRNSHolding(s) in Company
19th Nov 20185:47 pmRNSHolding(s) in Company
14th Nov 20187:30 amRNSResult of £1.25m Fundraise
14th Nov 20187:00 amRNSStrategic Alliance and Proposed Fundraise
8th Nov 20185:29 pmRNSCorrection to Interim Results
8th Nov 20187:00 amRNSInterim Results
1st Oct 20184:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.